Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Stem Cells (Dayton, Ohio)|March 11, 2015
Cardiosphere-derived cells from pediatric end-stage heart failure patients have enhanced functional activity due to the heat shock response regulating the secretomeSudhish Sharma, Rachana Mishra, David Simpson, et al.
Circulation Research|July 7, 2018
Stem Cell Therapy for Hypoplastic Left Heart Syndrome: Mechanism, Clinical Application, and Future DirectionsGregory J Bittle, David Morales, Kristopher B Deatrick, et al.
Iscience|October 23, 2023
Statistical modeling of extracellular vesicle cargo to predict clinical trial outcomes for hypoplastic left heart syndromeJessica R Hoffman, Hyun-Ji Park, Sruti Bheri, et al.
Cardiology in the Young|October 28, 2009
Innovation in basic science: stem cells and their role in the treatment of paediatric cardiac failure--opportunities and challengesSunjay Kaushal, Jeffrey Phillip Jacobs, Jeffrey G Gossett, et al.
Stem Cell Reviews and Reports|June 1, 2023
HSF-1 enhances cardioprotective potential of stem cells via exosome biogenesis and their miRNA cargo enrichmentSameer Ahmad Guru, Progyaparamita Saha, Ling Chen, et al.
The Journal of Experimental Medicine|July 29, 2021
Hypoxia-inducible factors individually facilitate inflammatory myeloid metabolism and inefficient cardiac repairMatthew DeBerge, Connor Lantz, Shirley Dehn, et al.
Circulation|January 19, 2011
Characterization and functionality of cardiac progenitor cells in congenital heart patientsRachana Mishra, Kalpana Vijayan, Evan J Colletti, et al.
Circulation Research|December 3, 2016
A Deep Proteome Analysis Identifies the Complete Secretome as the Functional Unit of Human Cardiac Progenitor CellsSudhish Sharma, Rachana Mishra, Grace E Bigham, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Augmentation of Histone Deacetylase 6 Activity Impairs Mitochondrial Respiratory Complex I in Ischemic/Reperfused Diabetic HeartsShelley L Baumgardt, Juan Fang, Xuebin Fu, et al.
Cardiovascular Research|July 13, 2024
Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia/reperfusion injury by limiting tumour necrosis factor alpha-induced mitochondrial injury in experimental diabetesShelley L Baumgardt, Juan Fang, Xuebin Fu, et al.
Pageof 9